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Case Report
Goblet Cell Carcinoma of the Appendix: A Case
Report on Goblet Cell Carcinoid
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Description

Goblet cell carcinoid of the appendix is a rare neoplasm with histological features of both
neuroendocrine and adenocarcinomas. The combination of its aggressive behavior, infrequent occurrence, and variable clinical presentation convolutes the management of this
tumor.
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We report the case of a 75-year-old female presenting with acute appendicitis. A laparoscopic appendectomy was performed. The pathology report showed goblet cell carcinoid at
the base of the appendix with involvement of the proximal surgical margins. At her postoperative visit, the patient’s pathology report and options for management were reviewed, and
the patient agreed to proceed with a right hemicolectomy 8-10 weeks after her appendectomy.
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Introduction

Tumors of the appendix are uncommon and
are encountered in about 1% of appendectomy specimens. Goblet cell carcinoids (GCC)
are a particularly rare subtype of appendiceal
neoplasms, accounting for less than 14% of
all appendiceal tumors.1 The origin of GCC is
unclear, but may be a pluripotent intestinal
epithelial crypt base stem cell. GCC exhibits
histologic features of both neuroendocrine and
glandular tissue, yet follows a more aggressive
course than classic neuroendocrine tumors
of the appendix. The incidence of GCC is 0.01
to 0.05 per 100000 per year and lends to the
relatively limited clinical experience with these
tumors.2 Previous studies suggest that there is
an equal male-to-female distribution and that
the mean age of diagnosis is in the mid to late
fifth decade.3 Clinical presentations of GCC are
varied, but most commonly involve abdominal
pain and acute appendicitis, which is seen in
over half of cases. Diagnosis is usually con-

firmed incidentally by a pathologist following
appendectomy or ileocecal resection. Roughly
25% of patients present with a perforated appendix and up to 50% of patients may present
with metastatic disease.3

Case Presentation

A 75-year-old female with a past medical history of hypertension presented with abdominal
pain. The patient reported the development of
abdominal pain starting 3 days prior to presentation. The pain started around her umbilicus
then radiated over to the right side of the
abdomen. The patient rated the pain level as
7/10 and described it as a sharp pain that was
constantly present. She complained of nausea
and vomiting since the pain started. She denied
diarrhea, any recent falls or injury, and any
exposure to ill contacts. On physical exam, her
vital signs were temperature of 37.6° Celsius,
pulse of 86 beats per minute, respirations of 16
breaths per minute, and blood pressure 142/89

www.hcahealthcarejournal.com
© 2020 HCA Physician Services, Inc. d/b/a
Emerald Medical Education

HCA Healthcare
Journal of Medicine

489

HCA Healthcare Journal of Medicine

Figure 1. Right colon attached to abdominal wall due to previous surgery (appendectomy).
mmHg. The abdomen was soft, without rebound or guarding. Positive tenderness at McBurney’s point (RLQ point 1/3 of the distance
from the iliac spine to the navel) was noted,
with negative Psoas and Obturator’s signs
(patient lies on his or her back with the hip and
knee both flexed at 90°). On admission, her
white blood cells were elevated at 15900/μL,
while her absolute neutrophils were elevated at
13400/μL. Her hemoglobin, and basic biochemistry panel were within normal limits. CT of
the abdomen and pelvis with contrast showed
findings consistent with acute appendicitis.
The patient was taken to the operating room
for urgent laparoscopic appendectomy. Grossly, the appendix appeared acutely inflamed
suggestive of acute appendicitis. Good hemostasis was visualized on the staple line and the
appendix was removed in an endocatch bag.
The patient recovered well from surgery and
did well on post op day 1. Her pain was well
controlled, she was ambulating and tolerating
a regular diet. The patient denied nausea and
vomiting, was urinating without issue and was
discharged in stable and improved condition on
post operative day 1.
The final pathology report showed goblet
cell carcinoid of the appendix with the tumor
involving the proximal surgical margin. The details of the pathology report are as follows:
Histologic sections revealed a neoplastic
proliferation comprised of uniform cells with
mucin vacuoles arranged in cohesive clusters
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infiltrating the appendiceal wall without eliciting a stromal reaction.
Immunohistochemical stains for pancytokeratin (CKAE1/AE3), Monoclonal CEA, CAM5.2,
CK7, CK20, CDX2, E-cadherin, chromogranin,
and synaptophysin were performed on paraffin-embedded tissue. Controls show appropriate reactivity with the following results in
tumor cells:
• Pancytokeratin (CKAE1/AE3): Positive.
• Monoclonal CEA: Positive.
• E-cadherin: Positive.
• CK7: Positive.
• CK20: Positive.
• CAM5.2: Positive.
• CDX-2: Positive.
• Synaptophysin: Focally positive.
• Chromogranin: Negative.
This immunoprofile supports the diagnosis of
goblet cell carcinoid.
During her postoperative visit at 2 weeks
post-operatively, the patient’s questions were
answered and she was given details on goblet cell carcinoid of the appendix including
management options. The patient decided to
proceed with a right hemicolectomy about 6
weeks after her initial surgery, as she wanted
to get the surgery done before an upcoming
trip. Pathology from the right hemicolectomy
showed no evidence of goblet cell carcinoid,
with 0 of 20 lymph nodes positive for carcinoid.
Small bowel and colonic segments were also
found to be free of carcinoid.
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Figure 2. Right colon with normal hepatic flexure and gallbladder.
The tumor invaded through the muscularis propria into the subserosa but did not extend into
the serosa. The proximal margin was involved
without evidence of lymphovascular involvement or regional lymph nodes. The pathological classification is pT3 N0 (tumor has grown
through the muscularis propria and into the
subserosa with no positive nodes). Figures 1-4
show the right hemicolectomy performed on
our patient with a da Vinci robot. Indocyanine
green was used to confirm adequate blood
flow in the transverse colon and the ileum.

They have an incidence of approximately 0.01 to
0.05 per 100,000 per year.4 The average age at
presentation is in the mid to late fifth decade.
Males and females are affected in roughly equal
ratios, but Caucasians are more likely to be
affected than other ethnicities. Patients most
commonly present with abdominal pain and/
or distension and a clinical picture consistent
with acute appendicitis. Some studies suggest
that up to 40% of cases present with distant
metastases to the peritoneum, liver, and/or
ovaries.4

Discussion

In general, patients with the following characteristics should undergo right hemicolectomy:5
tumors located at the base of the appendix,
tumors greater than 2 cm, pT3 or pT4 lesions,

Goblet cell carcinoids are extremely rare and
aggressive primary neoplasms of the appendix.

Figure 3. Indocyanin green showing adequate bloodflow in the transverse colon.
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Figure 4. Indocyanin green showing adequate bloodflow through the ileum.
higher grade histology with signet ring (Tang
grade B or C) locally advanced or with positive
surgical margins. Adjuvant chemotherapy with
5-fluorouracil has been recommended in patients with stage II (especially those with Tang
B and C), stage III, and stage IV disease due to
the high rate of relapse.5 Specifically, the 5-year
survival rates for stage II, III, and IV disease is
76%, 22%, and 14%, respectively.6 Literature
reports that the overall 5-year survival rates
for patients with combined stages II to IV who
underwent appendectomy versus right hemicolectomy were 43% and 34%, respectively
(P = 0.604) and the corresponding survival
rates for adjuvant chemotherapy versus no
chemotherapy were 32% and 27%, respectively (P = 0.151).7 For those patients with high
risk of relapse, various surveillance methods
have been suggested. These include scheduling office visits with a full history and physical
exam and obtaining laboratory measurement
of carcinoembryonic antigen (CEA) levels every
3 months. CT of chest, abdomen, and pelvis
should be done every 6 months for the first 2
years after diagnosis, then annually for up to 5
years.8
Patients who present with goblet cell carcinoid
raise suspicion for acute appendicitis and thus
routinely undergo CT imaging, which most
commonly supports the diagnosis. True diagnosis, however requires a tissue specimen, which
is most often procured during surgical resection. Histologically, these tumors express cell
markers and characteristics of both neuroen-
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docrine and glandular tissue. Notably, their behavior is more aggressive than neuroendocrine
tumors of the appendix. Due to the possibility
of spread, surgical management is often not
limited to simple appendectomy. Upon receipt
of the pathology report, the surgeon should
educate the patient regarding the risk for
distant metastasis and thus offer other treatments including chemotherapy and/or right
hemicolectomy, as was done in our case.
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